- Home
- ADAP vs BZFD Comparison
ADAP vs BZFD Comparison
Compare ADAP & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- BZFD
- Stock Information
- Founded
- ADAP 2008
- BZFD 2006
- Country
- ADAP United Kingdom
- BZFD United States
- Employees
- ADAP N/A
- BZFD N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- BZFD Movies/Entertainment
- Sector
- ADAP Health Care
- BZFD Consumer Discretionary
- Exchange
- ADAP Nasdaq
- BZFD Nasdaq
- Market Cap
- ADAP 71.6M
- BZFD 65.1M
- IPO Year
- ADAP 2015
- BZFD N/A
- Fundamental
- Price
- ADAP $0.24
- BZFD $1.73
- Analyst Decision
- ADAP Strong Buy
- BZFD
- Analyst Count
- ADAP 5
- BZFD 0
- Target Price
- ADAP $1.83
- BZFD N/A
- AVG Volume (30 Days)
- ADAP 2.6M
- BZFD 315.4K
- Earning Date
- ADAP 05-14-2025
- BZFD 05-12-2025
- Dividend Yield
- ADAP N/A
- BZFD N/A
- EPS Growth
- ADAP N/A
- BZFD N/A
- EPS
- ADAP N/A
- BZFD N/A
- Revenue
- ADAP $178,032,000.00
- BZFD $189,887,000.00
- Revenue This Year
- ADAP N/A
- BZFD $89.62
- Revenue Next Year
- ADAP $65.49
- BZFD $4.50
- P/E Ratio
- ADAP N/A
- BZFD N/A
- Revenue Growth
- ADAP 195.34
- BZFD N/A
- 52 Week Low
- ADAP $0.20
- BZFD $1.26
- 52 Week High
- ADAP $1.48
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- ADAP 37.78
- BZFD 37.09
- Support Level
- ADAP $0.23
- BZFD $1.65
- Resistance Level
- ADAP $0.26
- BZFD $1.79
- Average True Range (ATR)
- ADAP 0.04
- BZFD 0.15
- MACD
- ADAP 0.01
- BZFD -0.02
- Stochastic Oscillator
- ADAP 31.85
- BZFD 15.25
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.